![]() |
|
|
Molecular Pharmacology, Vol 17, 328-338, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Cell Biology, Baylor College of Medicine, Houston, Texas 7703
2 Department of Medicine, Baylor College of Medicine, Houston, Texas 77030
3 Department of Cell Biology, Baylor College of Medicine, Houston, Texas 7703, and Physiologisches Institut der Universität Dusseldorf, Lehrstuhl fur Klimische Physiologie, Dusseldorf, West Germany
Hydroxybenzylpindolol (HYP) has been subjected to iodination using a chloramine-T
method. We have studied the products of iodination and determined both the chemical
and pharmacological properties of one of the iodinated species of HYP. Routine iodination
consistently resulted in two labeled products separable by QAE-Sephadex, paper and
high-pressure liquid chromatography. The pattern of elution on high-pressure liquid
chromatograms varied with the source and age of the 125I used. Optimized conditions led
to a major peak of iodohydroxybenzylpindolol (I-HYP). This peak was relatively stable
to incubation at 37°C (66% remaining after 2 h). It chromatographed on paper with an Rf
similar to that reported for I-HYP by M. E. Maguire, R. A. Wiklund, H. J. Anderson and
A. G. Gilman (J. Biol. Chem. 251: 1221-1231, 1976). Ultraviolet titration curves and
NMR spectra indicated that iodination occurs neither on the hydroxybenzyl moiety of
HYP nor on the benzylic portion of the indole moiety of HYP. Spectra are consistent
with iodination occurring at position 3 of the indole moiety of HYP. Pharmacological
properties were studied both on kitten ventricular membranes and on isolated kitten atria
and papillary muscles. I-HYP competitively blocked isoproterenol stimulation of kitten
ventricular membrane adenylyl cyclase with pKBs (-log KB) that ranged from 9.2 to 9.4,
which were indistinguishable from pKBS for HYP determined simultaneously. I-HYP
acted as a partial agonist in the isolated organ assays. Calculations performed as described
by M. Marano, and A. J. Kaumann (J. Pharmacol. Exp. Ther. 198: 518-525, 1976)
yielded pKps for I-HYP for competition against isoproterenols interaction with chronotropic and inotropic
-adrenergic receptors in right atria, left atria, and papillary muscles
of 9.2, 9.4, and 8.7, respectively. EC50s (effective concentrations giving 50% of maximum
response for partial stimulation of chronotropic and inotropic receptors) in the same
tissues, on the other hand, were (-log molar) 7.3, 7.3, and 7.1, respectively. Thus, I-HYP,
as HYP (Kaumann, A. J., L. Birnbaumer and R. Wittman, in Receptors and Hormone
Action, L. Birnbaumer and B. W. OMalley, Eds., Vol. 3, 134-177, Academic Press, New
York, 1978) behaves in kitten cardiac tissues as a partial agonist that initiates stimulation
of response only at concentrations at which it causes better than 97.5% occupancy of
-receptors.
Note:
ACKNOWLEDGMENTS
We thank Dr. Wayne Wray for the use of his Heath spectrophotometer, Mrs. Barbara Adrian for her excellent technical assistance, and
Ms. Nancy Gammage for her efficient preparation of the manuscript.